Clinical Trial Update: Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gefitinib (Iressa) with or without concurrent chemoradiotherapy in advanced non-nasopharyngeal head and neck cancer; study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED